This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Hilde Bastaerts, PharmD
Pharmaceutical Quality Specialist at European Medicines Agency
Speaker

Profile

Hilde holds a M.Sc. in Pharmaceutical Sciences from Ghent University, and a certificate in Industrial Pharmacy (EU qualified person).

She has >25 years of experience in pharmaceutical industry, in various functions in quality assurance/quality control, as well as CMC development and CMC regulatory affairs. In 2021 she joined the European Medicines Agency, where she works in the Pharmaceutical Quality Office as a senior pharmaceutical quality specialist. In her current role she supports procedures for initial marketing authorisations (centralised procedures), scientific advices, and postapproval variations, interacting with QWP, BWP and CHMP. She is a member of the drafting group working on the synthetic peptide and oligonucleotide guidelines.

Agenda Sessions

  • Synthetic Peptides – Scientific Considerations on Pharmaceutical Quality Aspects: EMA Experience and Future Outlooks

    10:30